For citations:
Wang Y., Bulatova N.R., Klen E.E., Rozit G.A., Nikitina I.L., Smolyarchuk E.A., Zavadich K.A., Krylova I.D., Samorodov A.V. Results of Preclinical Studies of 4-(2-(4-nitrophenyl)-2-oxoethyl)-1-(thietane-3-yl)-1H-1,2,4-triazole-4-th Bromide in Relation to the Hemostasis System in vivo. Drug development & registration. 2024;13(1):241-246. https://doi.org/10.33380/2305-2066-2024-13-1-1653
Email this article 